NCT07683754
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07683754
Title T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd (DB-Guide)
Acronym DB-Guide
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Daiichi Sankyo
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Maryland Oncology Hematology, P.A. RECRUITING Columbia Maryland 21044 United States Details
Comprehensive Cancer Centers of Nevada RECRUITING Las Vegas Nevada 89144 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology - West Texas RECRUITING El Paso Texas 79902 United States Details
Texas Oncology - San Antonio RECRUITING New Braunfels Texas 78130 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field